Understand common adult weight-management criteria, product-specific assessment and the questions to ask when a prescription decision is still pending.
Published . Updated .
This article promotes CoreAge Rx and includes commercial links. Service claims are attributed to CoreAge Rx; medical and regulatory information is linked to its sources.
The Weight Weight is an educational publisher, not a medical provider. A clinician must assess your care. Read our medical and commercial disclosures.
Common criteria are the beginning of the assessment
NIDDK says clinicians may consider weight-management medication for adults with a BMI of at least 30, or at least 27 with a weight-related health problem such as high blood pressure or type 2 diabetes. It also explains that these medicines are not appropriate for everyone with a high BMI.
These are general adult weight-management considerations. The exact product, intended use, medical history, other medicines and expected benefits and risks still matter. They are not a rule for every use of every GLP-1 medicine, every age group or every provider.
What the BMI calculation establishes
CDC’s BMI FAQ gives the U.S. formula: weight in pounds divided by height in inches squared, multiplied by 703. A person who is 66 inches tall and weighs 190 pounds has a BMI of approximately 30.7. That describes weight relative to height. It does not mean 30.7 percent body fat or establish automatic eligibility for a prescription.
BMI cannot distinguish fat, muscle and bone or show where fat is carried. CDC recommends considering other health information alongside it. Our BMI and body-fat guide explains how to label measurements and bring the right question to the clinician.
Explain the health concern behind the request
Share diagnoses you already have, relevant symptoms and the care you receive for them. A list of possible weight-related conditions on a website does not diagnose you or prove that a particular drug is suitable.
If the clinician needs records, ask which ones and what question they will help answer. Do not seek a new diagnosis simply to clear an intake threshold. The aim is an accurate assessment of your health and appropriate options.
Check the proposed product’s precautions
NIDDK’s medication guidance advises discussing existing medical conditions, other medicines, possible side effects and the risks and benefits of treatment. Give a complete account of allergies, relevant family history, previous treatment difficulties and pregnancy or breastfeeding plans.
Ask the prescriber to explain contraindications and warnings for the exact medicine proposed. A general article cannot supply a complete safety assessment, and warnings for one product should not be casually applied to every other product. Do not start, stop or change a prescription based on an eligibility checklist.
Ask how the service reaches a clinical decision
For CoreAge Rx, the published intake process describes collecting medical history, current medicines and allergies, plus identification and photos. A clinician reviews the information and may ask follow-up questions before approval. Completing the form and receiving a prescription are separate steps.
Ask how to correct an inaccurate entry, provide requested records and understand the reason for a recommendation. The communication format alone does not prove that every clinical question has been answered. Use our appointment-goals guide to keep the next conversation focused.
Clarify whether testing would answer a clinical question
If the clinician recommends a test, ask what it is intended to clarify, who orders it, where you can have it done, what it costs and who explains the result. If you have recent relevant results, ask whether those can be used.
A service’s statement that it does not routinely require a test does not establish that you personally need no testing. Conversely, this article does not prescribe a universal screening panel. The assessment should determine what information is needed.
Confirm the program’s actual availability
Check the service’s current age and location requirements directly. A provider’s marketing reach is not a guarantee that it offers the proposed care where you will receive it, or that you meet its clinical criteria.
For a child or teenager, seek an age-appropriate assessment. CDC uses a different interpretation of BMI for ages 2 through 19 than for adults 20 and older; an adult calculator is not a substitute for that assessment.
When the answer is no or more information is needed
Ask what the decision means: a medical concern, missing information, the program’s limits or a payment/coverage issue. Those situations call for different next steps. Request the reasoning and ask what appropriate care or further assessment is recommended.
A lower price does not by itself establish a reason to use a compounded medicine. FDA advises using compounded drugs only when a patient’s medical needs cannot be met by an approved drug. Compounded products are not FDA-approved, and a denial does not make a compounded offer an automatic substitute.
Frequently asked questions
Does meeting a BMI threshold guarantee approval?
No. It supplies one part of a broader clinical assessment. The exact treatment and your medical situation must still be evaluated.
Can family history alone tell me which medication to use?
No. Share it because it can be relevant, then ask how it affects your assessment. It is not a prescription or a reason to order a specific test yourself.
What does CoreAge Rx offer?
Its product overview lists compounded semaglutide and tirzepatide among its prescription offerings. A clinician must decide whether a proposed treatment is appropriate; the menu does not establish eligibility.